Skip to content
HowShorted

Aligos Therapeutics, Inc. short interest in 2026

In 2026, Aligos Therapeutics, Inc.'s disclosed short interest ran from 1.71% of shares outstanding on 15 Jan 2026 to 5.59% on 15 Sep 2026, a change of +3.88 percentage points. The year's high was 5.59% on 15 Sep 2026 and its low 1.71% on 15 Jan 2026, averaging 3.59% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.35 days on 15 Sep 2026. Full history: Aligos Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Aligos Therapeutics, Inc. in 2026

2026 in figures

Start of year
1.71% (15 Jan 2026)
End of year
5.59% (15 Sep 2026)
Change
+3.88 pp
High
5.59% (15 Sep 2026)
Low
1.71% (15 Jan 2026)
Average
3.59%
Highest days to cover
15.35 (15 Sep 2026)
SEC filings marked
6

Every report in 2026

Aligos Therapeutics, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 20261.71%3.58
30 Jan 20261.87%3.46
13 Feb 20261.84%5.37
27 Feb 20261.84%11.57
13 Mar 20262.38%6.4510-K filed, results (8-K)
31 Mar 20262.47%7.59
15 Apr 20262.23%4.55
30 Apr 20263.96%1.00
15 May 20264.32%3.4510-Q filed, results (8-K)
29 May 20264.66%4.75
15 Jun 20264.94%6.13
30 Jun 20264.39%7.94
15 Jul 20264.21%1.01
31 Jul 20264.90%6.39
14 Aug 20264.55%2.7110-Q filed, results (8-K)
31 Aug 20265.19%9.41
15 Sep 20265.59%15.35

See also: Aligos Therapeutics, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.